ArticlePhysical and engineering sciences in medicine2026
A CNN-transformer fusion for EEG-based discrimination of Alzheimer's and frontotemporal dementia.
Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dementia is a progressive neurodegenerative disorder that severely impacts cognitive functions and daily living, especially in aging populations. Among its subtypes, Alzheimer's disease (AD) and frontotemporal dementia (FTD) exhibit overlapping clinical symptoms, making early and accurate differentiation a critical challenge. Electroencephalography (EEG), as a non-invasive and cost-effective modality, provides valuable insights into the neurophysiological disruptions associated with these conditions. This study aims to develop a robust EEG-based diagnostic framework capable of accurately classifying AD, FTD, and healthy controls (HC) by integrating domain-specific signal processing with advanced deep learning techniques. This study employed a publicly accessible dataset consisting of resting-state EEG recordings from a total of 88 participants, comprising 29 individuals with AD, 23 diagnosed with FTD, and 36 age-matched HC. The proposed model integrates Common Spatial Pattern (CSP) filtering with a sequential modified hybrid architecture that combines Convolutional Neural Networks (CNNs) and a Vision Transformer (ViT). By fusing domain-informed spatial filtering with deep hierarchical feature learning, the model captures both local signal characteristics and global contextual dependencies. A 10-fold cross-validation approach was employed to assess model performance and generalizability. The proposed model achieved notable classification accuracies of 95.86%, 94.76%, 94%, and 92.14% for the AD/HC, FTD/HC, AD/FTD, and AD/FTD/HC classification tasks, respectively. These results underscore the diagnostic potential of EEG-based deep learning frameworks in distinguishing among neurodegenerative conditions and highlight their promise in supporting more precise and individualized clinical interventions. This study presents a novel end-to-end EEG classification pipeline that fuses domain-guided spatial filtering with deep neural feature learning. The promising results suggest that the proposed method could serve as a valuable component in future clinical decision support systems for dementia, contingent upon further validation in real-world clinical settings.
Indexed as
Identifiers
41774419What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.